课题基金 / 基金详情

Fluorogenic imaging molecules for protease/kinase assays

Fluorogenic imaging molecules for protease/kinase assays
用于蛋白酶/激酶测定的荧光成像分子
批准号:
6486243
负责人:
JOHN ARCHDEACON
金额:
$9.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-23 至 2003-08-31

项目摘要

项目成果

JOHN ARCHDEACON的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The aim of this proposal is to develop a series of fluorogenic imaging molecules, which can be easily delivered into viable cells and monitor cellular functions. The FIMs are composed of a peptide backbone containing a target site for a kinase or a protease. Some designs borrow from the molecular beacon approach and carry flurophore/quencher moieties, while other designs simply carry a flurophore only. When present, the quencher moiety is internal to the FIM rather than at the extreme N- and C-terminus, as has been the case with other similar type beacons. This avoids the need for structural constraint, which aims to be imposed in order to bring the flurophore and quencher into close proximity to each other thereby preventing background fluorescence. Specifically, the scope of this proposal will cover the design, synthesis and testing of two peptides containing cleavage sites specific for caspase-1 (ICE) and caspase-3 (CPP32). Also included in this proposal is the design, synthesis and testing of fluorogenic peptides derived from a differentially phosphorylated, essential domain of human cdd25C phosphatase, which is involved in induction of the mitotic process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel conformation-based nuclear receptor activity assay
  • 批准号:
    6691855
  • 项目类别:
  • 资助金额:
    $9.95万
  • 财政年份:
    2003
  • 负责人:
    JOHN ARCHDEACON
  • 依托单位:
In vivo transcription factor DNA binding analysis
  • 批准号:
    6643757
  • 项目类别:
  • 资助金额:
    $9.99万
  • 财政年份:
    2003
  • 负责人:
    JOHN ARCHDEACON
  • 依托单位:
Novel 5'-end tagging of mRNA for cDNA synthesis or RACE
  • 批准号:
    6337791
  • 项目类别:
  • 资助金额:
    $9.27万
  • 财政年份:
    2001
  • 负责人:
    JOHN ARCHDEACON
  • 依托单位: